Search Results 21-30 of 8855 for optum fsa eligible items

  1. Pembrolizumab In Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant ...

  2. New evidence supports ablation for heart failure patients with atrial fibrillation - Mayo Clinic News Network

    Of these patients, less than 8% would have been fully eligible ... Among those who would have been eligible to ... OptumLabs is a collaborative center for research ...

  3. A Study Of The Use Of A New Drug In People With Non-Alcoholic Steatohepatitis (NASH) Or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. A Study to Understand the Mechanisms of Normal and Disordered Defection - Mayo Clinic

    Participation eligibility. Participant eligibility includes age ... Exclusion Criteria for Controls (items marked with an asterisk also apply to patients):.

  5. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction - Mayo Clinic

    Patients transferred in to an UPSTREAM hospital are eligible for inclusion ... Mayo Clinic does not endorse any of the third party products and services ...

  8. Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. Study Evaluating Efficacy And Safety Of Octagam 10% In Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. A Study Of The Safety And Effectiveness Of Suvorexant (MK-4305) For The Treatment Of Insomnia In People Who Have Alzheimer's Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender ... items on the Insomnia Diagnostic Interview and Sleep History assessments, e.g..